Efficacy of 448kilohertz Capacitive Resistive Monopolar Radiofrequency Stimulation in Chronic Shoulder Pain
Unknown statusNot applicableNCT04245969
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.
Brief summary (from the registry)
448kilohertz capacitive resistive monopolar radiofrequency is a novel technique in physiotherapy and its usefulness and clinical relevance is still to be investigated. Current studies show promising results in different musculoskeletal disorders, however further studies with proper designs and conclusive findings are necessary.
Study details
- Official title
- Efficacy of 448kilohertz Capacitive Resistive Monopolar Radiofrequency Stimulation in Chronic Shoulder Pain: A Randomised Controlled Trial
- Conditions
- Interventions
- Device: Experimental: 448 kilohertz Capacitive Resistive Monopolar Radiofrequency stimulus
- Other: Sham comparator
- Other: No intervention
- Sponsor
- University of Malaga
- Start date
- 2020-03-30
- Primary completion
- 2020-05-30
- Sex
- All
- Age range
- from 18 Years to 65 Years
- Results posted
- No results posted in this snapshot
- Total sites listed
- 0
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: * To suffer from shoulder pain more than three months. * Men or women aged between 18 to 65 years; * Unilateral pain located in the anterior and/or lateral shoulder region; * 2 out of 3 positive clinical tests (Hawkins-Kennedy; Jobe; Neer); * Pain with normal activity ≥ 4/10 on a visual analogue scale; * Nontraumatic onset of shoulder pain. Exclusion Criteria: * History of significant shoulder trauma, such as fracture or ultrasonography-clinically suspected full thickness cuff tear, following the classification of Wiener and Seitz * Recent shoulder dislocation in the past two years * Systemic illnesses such as rheumatoid arthritis * Adhesive capsulitis of the shoulder * Shoulder pain originating from the neck or if there was a neurological impairment, osteoporosis, hemophilia and/or malignancies.
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT04245969